Evaluation of portability and cost of a fluorescent PCR ribotyping protocol for Clostridium difficile epidemiology

dc.contributor.authorMartinson, Jonathan N.V.
dc.contributor.authorBroadaway, Susan C.
dc.contributor.authorLohman, Egan J.
dc.contributor.authorJohnson, Christina
dc.contributor.authorAlam, M. Jahangir
dc.contributor.authorKhaleduzzaman, Mohammed
dc.contributor.authorGarey, Kevin W.
dc.contributor.authorSchlackman, Jessica
dc.contributor.authorYoung, Vincent B.
dc.contributor.authorSanthosh, Kavitha
dc.contributor.authorRao, Krishna
dc.contributor.authorLyons, Robert H. Jr
dc.contributor.authorWalk, Seth T.
dc.date.accessioned2016-05-19T15:40:23Z
dc.date.available2016-05-19T15:40:23Z
dc.date.issued2015-01
dc.description.abstractClostridium difficile is the most commonly identified pathogen among health care-associated infections in the United States. There is a need for accurate and low-cost typing tools that produce comparable data across studies (i.e., portable data) to help characterize isolates during epidemiologic investigations of C. difficile outbreaks and sporadic cases of disease. The most popular C. difficile-typing technique is PCR ribotyping, and we previously developed methods using fluorescent PCR primers and amplicon sizing on a Sanger-style sequencer to generate fluorescent PCR ribotyping data. This technique has been used to characterize tens of thousands of C. difficile isolates from cases of disease. Here, we present validation of a protocol for the cost-effective generation of fluorescent PCR ribotyping data. A key component of this protocol is the ability to accurately identify PCR ribotypes against an online database (http://walklab.rcg.montana.edu) at no cost. We present results from a blinded multicenter study to address data portability across four different laboratories and three different sequencing centers. Our standardized protocol and centralized database for typing of C. difficile pathogens will increase comparability between studies so that important epidemiologic linkages between cases of disease and patterns of emergence can be rapidly identified.en_US
dc.description.sponsorshipNational Institute of Health Grant K01AI09728101 (to S.T.W.); Claude D. Pepper Older American Independence Center Grant AG-024824 (to K.R.); Texas Department of State Health Services Grant 2014-045577 (to K.W.G.)en_US
dc.identifier.citationMartinson, Jonathan N. V., Susan Broadaway, Egan Lohman, Christina Johnson, M. Jahangir Alam, Mohammed Khaleduzzaman, Kevin W. Garey, et al. “Evaluation of Portability and Cost of a Fluorescent PCR Ribotyping Protocol for Clostridium Difficile Epidemiology.” Edited by A. B. Onderdonk. Journal of Clinical Microbiology 53, no. 4 (January 28, 2015): 1192–1197. doi:10.1128/jcm.03591-14.en_US
dc.identifier.issn0095-1137
dc.identifier.urihttps://scholarworks.montana.edu/handle/1/9822
dc.titleEvaluation of portability and cost of a fluorescent PCR ribotyping protocol for Clostridium difficile epidemiologyen_US
dc.typeArticleen_US
mus.citation.extentfirstpage1192en_US
mus.citation.extentlastpage1197en_US
mus.citation.issue4en_US
mus.citation.journaltitleJournal of Clinical Microbiologyen_US
mus.citation.volume53en_US
mus.data.thumbpage4en_US
mus.identifier.categoryHealth & Medical Sciencesen_US
mus.identifier.categoryLife Sciences & Earth Sciencesen_US
mus.identifier.doi10.1128/jcm.03591-14en_US
mus.relation.collegeCollege of Agricultureen_US
mus.relation.collegeCollege of Letters & Scienceen_US
mus.relation.departmentMicrobiology & Immunology.en_US
mus.relation.universityMontana State University - Bozemanen_US

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
JournalClinicalMicrobiology_53_4_2015.pdf
Size:
206.48 KB
Format:
Adobe Portable Document Format
Description:
Evaluation of portability and cost of a fluorescent PCR ribotyping protocol for Clostridium difficile epidemiology (PDF)

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
826 B
Format:
Item-specific license agreed upon to submission
Description:
Copyright (c) 2002-2022, LYRASIS. All rights reserved.